Why isn’t treatment for depression leading to lower prevalence?

Population health guru Professor Tony Jorm asks why we’re not seeing sufferer numbers drop

Eric van Bemmel

Published 29 July 2016

Episode 373

In this episode of the Up Close podcast, public health researcher Professor Tony Jorm asks why prevalence of anxiety and depression in North America, Australia and elsewhere has not decreased despite a quarter century of more and better treatment for two of the world’s most common mental health problems.

“Although more people are getting treatment, it may not be very good treatment ... we hypothesize there is actually a quality gap,” he says.

中国地区的听众可以通过此链接收听播客节目

Subscribe to Up Close through iTunes.

Find out more about research in this faculty

Medicine, Dentistry and Health

Content Card Slider


Content Card Slider


Subscribe for your weekly email digest

By subscribing, you agree to our

Acknowledgement of country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities
Phone: 13 MELB (13 6352) | International: +61 3 9035 5511The University of Melbourne ABN: 84 002 705 224CRICOS Provider Code: 00116K (visa information)